Drug Report History #278132

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v1-EN
Language English English
Date Updated (Changed) Updated to: 2026-02-23 Was: 2026-02-13
Drug Identification Number 02547686 02547686
Brand name CYCLOPHOSPHAMIDE FOR INJECTION USP CYCLOPHOSPHAMIDE FOR INJECTION USP
Common or Proper name CYCLOPHOSPHAMIDE FOR INJECTION USP CYCLOPHOSPHAMIDE FOR INJECTION USP
Company Name STERIMAX INC STERIMAX INC
Ingredients CYCLOPHOSPHAMIDE CYCLOPHOSPHAMIDE
Strength(s) 1000MG 1000MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1 VIAL 1 VIAL
Additional packaging sizes
ATC code L01AA L01AA
ATC description ALKYLATINGAGENTS ALKYLATINGAGENTS
Reason for shortage Demand increase for the drug. Demand increase for the drug.
Anticipated start date (Changed) Updated to: Was: 2026-04-10
Actual start date (Changed) Updated to: 2026-02-20 Was:
Estimated end date Unknown Unknown
Actual end date
Shortage status Anticipated shortage Anticipated shortage
Tier 3 Status (Changed) Updated to: Yes Was: No
Company comments For urgent requests, please contact SteriMax at 1-800-881-3550. For urgent requests, please contact SteriMax at 1-800-881-3550.
Health Canada comments